
Isomorphic Labs
Isomorphic Labs is a logo (device) trademark application, number 7470216, in —, filed on 22 Sep 2025. Its status on the Indian trademark register is “Accepted & Advertised”, last checked 14 Sep 2026.
[CLASS : 5] Pharmaceutical preparations. [CLASS : 9] Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. [CLASS : 42] Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service [saas] services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.
What this status means
The examiner accepted the application and it has been published in the Trade Marks Journal. Anyone can oppose it during the opposition period.
More about “Advertised”Documents on file
Quick answers
- What is the status of the Isomorphic Labs trademark?
- Accepted & Advertised, as of 14 Sep 2026. The examiner accepted the application and it has been published in the Trade Marks Journal. Anyone can oppose it during the opposition period.
- Can the Isomorphic Labs trademark be opposed?
- Yes. It was advertised in Trade Marks Journal No. 2278 on 14 Sep 2026; a notice of opposition (Form TM-O) can be filed until 14 Jan 2027. See Journal No. 2278
What to do about “Advertised”: yourself, or with an expert
The government fee is the same either way. Here is exactly what the portal asks for, and what an expert would do differently.
- Your application number and the Journal number/date from the publication details.
- Check the status every few weeks on the register.
- If the status becomes 'Opposed', the counter-statement deadline (2 months) starts from when you receive the notice.
- If four months pass with no opposition, the registration certificate is issued and can be downloaded from the portal's documents.
- Changing your address or email without recording it: opposition notices go to the address on record.
- Assuming advertisement means registration; ® may only be used after the certificate.
- Monitors the Journal and the status, and is ready with the counter-statement the day an opposition appears.
Should you file yourself or use an expert?Six honest differences, and when DIY is fine
- It is a plain word mark (no logo) in one class.
- The search shows no identical or sound-alike live mark in that class.
- You have, or will get, a Class 3 DSC and are comfortable with online forms.
- You can describe your goods or services precisely and will check the status every month for a year or two.
- Government fee: the same whoever files (₹4,500 or ₹9,000 per class).
- Yourself: plus a DSC (about ₹1,000 to ₹1,500) and your time.
- With Invorn: a professional fee on top of the government fee, shown on the fee table. Free consultation first; if you are not happy before the application is submitted, the fee is refunded.
Invorn: search + filing from ₹1,299 + govt fee · objection reply ₹1,949 (no govt fee). Full fee table.
Ask which path fits your case- Filed by a Registered Trade Marks Agent
- 7-day refund policy
- No spam, numbers never sold
- Register checked on 14 Sept, 05:30 am IST
Last checked against the register on 14 Sept, 05:30 am IST. Owner addresses are not published. About this data